Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Vrdoljak, Danko Velimir"'
Autor:
Korolija-Marinic, Dragan, Ćurt, Loris, Penavić, Ivan, Tomasović, Hrvoje, Lesar, Miroslav, Mušterić, Goran, Tometic, Gordan, Vrdoljak, Borna, Vrdoljak, Danko Velimir
Publikováno v:
In European Journal of Surgical Oncology February 2024 50(2)
Autor:
Belac Lovasić, Ingrid, Bašić Koretić, Martina, Podolski, Paula, Dedić Plavetić, Natalija, Silovski, Tajana, Pleština, Stjepko, Jazvić, Marijana, Soldić, Željko, Šeparović, Robert, Tečić Vuger, Ana, Beketić Orešković, Lidija, Tomaš, Ilijan, Flam, Josipa, Petrić Miše, Branka, Ban, Marija, Telesmanić Dobrić, Vesna, Budisavljević, Anuška, Jović Zlatović, Josipa, Nalbani, Marijo, Vojnović, Željko, Marušić, Zlatko, Tomić, Snježana, Avirović, Manuela, Štambuk, Bojan, Vrdoljak, Danko Velimir, Prutki, Maja, Brkljačić, Boris, Tadić, Tade, Mijatović, Davor, Stanec, Zdenko, Milas, Ivan, Vrdoljak, Eduard
Publikováno v:
Liječnički vjesnik
Volume 144
Issue 9-10
Volume 144
Issue 9-10
Rak dojke je najčešći zloćudni tumor u žena koji se može probirom, redovitim kontrolama i zdravstvenim odgojem otkriti u ranim stadijima bolesti i uspješno liječiti. Metode liječenja uključuju kirurgiju, kemoterapiju, radioterapiju, endokri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8dbd0981fe58865eecc7604f4ae6e622
https://urn.nsk.hr/urn:nbn:hr:105:977208
https://urn.nsk.hr/urn:nbn:hr:105:977208
Autor:
Skoko, Marija, Mihić Lasan, Irena, Bilić, Karmen, Štefić, Anita, Jularić, Anamarija, Dodig, Javorka, Bošnjak, Tomislav, Misir Šitum, Stanka, Brozović, Gordana, Vrdoljak, Danko Velimir, Mihaljević, Mihaela, Vučemilo, Tiha, Marinković Strumberger, Tara
Background : In the past, chirrotic patients were usually consid-ered as patients with high risk of bleeding and hipocoagulability. The common practice was to correct coagulation parameters with plasma products and platelet. Cirrhosis is characterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::74f70f0ab27589f402c405b8da8c365d
https://doi.org/10.1002/rth2.12589
https://doi.org/10.1002/rth2.12589
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gabrić, Dragana, Brailo, Vlaho, Ivek, Aleksandra, Krpan, Karla, Matulić, Nena, Vrdoljak, Danko Velimir, Baraba, Anja, Vučićević Boras, Vanja
The use of lasers for treatment of oral leukoplakia has gained a lot of interest in the past years, however, data on the use of Er:YAG laser are scarce. The aim of this study was to compare the efficacy of Er:YAG laser and 1% topical isotretinoin in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::37df7652c6d9a04e557a64cd37f80d56
https://www.bib.irb.hr/1058341
https://www.bib.irb.hr/1058341
Autor:
Kirac, Iva, Zigman, Tamara, Snjezana, Ramic, Oresic, Tomislav, Milas, Ivan, Vrdoljak, Danko Velimir
Publikováno v:
In European Journal of Surgical Oncology February 2022 48(2):e143-e143
Autor:
Silovski, Tajana, Pleština, Stjepko, Belev, Borislav, Dobrila Dintinjana, Renata, Kurbel, Sven, Županc, Darko, Vrdoljak, Danko Velimir, Škegro, Mate, Vidović, Marina, Šeparović, Robert, Vrbanec, Damir
Treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______579::1956b14bd3b11022808e436644858f0c
https://hrcak.srce.hr/178437
https://hrcak.srce.hr/178437
Autor:
Silovski, Tajana, Pleština, Stjepko, Belev, Borislav, Dobrila-Dintinjana, Renata, Kurbel, Sven, Županc, Darko, Vrdoljak, Danko Velimir, Škegro, Mate, Vidović, Marina, Šeparović, Robert, Vrbanec, Damir
Publikováno v:
Liječnički vjesnik
Volume 139
Issue 1-2
Volume 139
Issue 1-2
Liječenje onkoloških bolesnika mora se temeljiti na multidisciplinarnom pristupu, a provodi se u specijaliziranim onkološkim centrima. Nakon završetka specifičnog onkološkog liječenja daljnje praćenje uglavnom provode onkolozi, ali je uloga l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8ee9e259004fd8ef05046b320d0dcab3
https://repository.medri.uniri.hr/islandora/object/medri:3679
https://repository.medri.uniri.hr/islandora/object/medri:3679
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In European Journal of Surgical Oncology February 2020 46(2):e124-e124